Global Search | Novartis

Hide Filters

Sort by

Relevance

Newest first

Oldest first

Showing 163 results

Pulse Update / Feb 16, 2024
Novartis appoints Sloan Simpson as Global Head of Investor Relations
Pulse Update / Jan 08, 2024
Novartis shares strategy and growth update at J.P. Morgan Healthcare Conference 2024
Featured News / Nov 24, 2020
Meet Novartis Management 2020
Annual meeting highlights progress on the company’s transformation and growth strategy.
Statement / Oct 19, 2023
Violence against innocent people runs counter to our work to improve human health
Statement / Oct 13, 2023
Novartis condemns the terrorist actions against people in Israel and loss of innocent lives
Featured News / Sep 13, 2023
Novartis’ Giving & Volunteering wins ACCP’s 2023 Corporate Social Impact Team of the Year Award
Statement / Sep 19, 2023
Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
Novartis and BeiGene, Ltd. have mutually agreed to terminate the collaboration and license agreement for tislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody.
Statement / Sep 13, 2023
Novartis provides support for Moroccan earthquake victims
Statement / Sep 11, 2023
GT005 (PPY988): Development Program in Geographic Atrophy
Statement / Sep 01, 2023
Novartis statement on filing of Inflation Reduction Act lawsuit